Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Rondoni · SciRah

Researcher profile · Semantic Scholar

M. Rondoni

Share profile

M. Rondoni — researcher profile on SciRah

h-index: 24
Works: 138
Citations: 1,949

Most-cited papers

Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia.
J. Jovanovic, J. Score, K. Waghorn, D. Cilloni +19 more
2007Blood208 citations Open access
Semantic Scholar
Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain.
S. Soverini, Sabrina Colarossi, A. Gnani, F. Castagnetti +15 more
2007Haematologica203 citations Open access
Semantic Scholar
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRα-positive hypereosinophilic syndrome. Results of a multicenter prospective study
M. Baccarani, D. Cilloni, M. Rondoni, E. Ottaviani +17 more
2007Haematologica201 citations Open access
Semantic Scholar
Characteristics and outcome of therapy‐related myeloid neoplasms: Report from the Italian network on secondary leukemias
L. Fianchi, L. Pagano, A. Piciocchi, A. Candoni +23 more
2015American journal of hematology/oncology117 citations Open access
Semantic Scholar
Presence or the emergence of a F317L BCR-ABL mutation may be associated with resistance to dasatinib in Philadelphia chromosome-positive leukemia.
S. Soverini, G. Martinelli, Sabrina Colarossi, A. Gnani +15 more
2006Journal of Clinical Oncology76 citations Open access
Semantic Scholar
CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in Adults
F. Lanza, E. Maffini, M. Rondoni, E. Massari +2 more
2020Cancers69 citations Open access
Semantic Scholar
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients
L. Pieri, P. Bonadonna, C. Elena, C. Papayannidis +29 more
2016American journal of hematology/oncology59 citations Open access
Semantic Scholar
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program
F. Guolo, L. Fianchi, P. Minetto, M. Clavio +32 more
2020Blood Cancer Journal57 citations Open access
Semantic Scholar
Advanced mast cell disease: an Italian Hematological Multicenter experience
L. Pagano, C. Valentini, M. Caira, M. Rondoni +20 more
2008International journal of hematology45 citations Open access
Semantic Scholar
Second-line treatment with dasatinib in patients resistant to imatinib can select novel inhibitor-specific BCR-ABL mutants in Ph+ ALL.
S. Soverini, G. Martinelli, Sabrina Colarossi, A. Gnani +5 more
2007The Lancet Oncology42 citations
Semantic Scholar
Complete molecular response in CML after p210 BCR–ABL1-derived peptide vaccination
M. Bocchia, M. Defina, L. Aprile, M. Ippoliti +4 more
2010Nature Reviews Clinical Oncology36 citations
Semantic Scholar
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis
G. Martinelli, M. Mancini, C. De Benedittis, M. Rondoni +28 more
2017Leukemia33 citations Open access
Semantic Scholar
Mast cell leukemia: a report of ten cases
C. Valentini, M. Rondoni, E. Pogliani, M. T. van Lint +7 more
2008Annals of Hematology33 citations
Semantic Scholar
Extraperitoneal radical cystectomy and ureterocutaneostomy in octogenarians
C. de Nunzio, A. Cicione, F. Leonardo, M. Rondoni +4 more
2011International Urology and Nephrology30 citations
Semantic Scholar
Real‐world experience with decitabine as a first‐line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy
M. Bocchia, A. Candoni, E. Borlenghi, M. Defina +38 more
2019Hematological Oncology25 citations Open access
Semantic Scholar
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia
D. Cilloni, F. Messa, Giovanni Martinelli, E. Gottardi +17 more
2007Leukemia24 citations Open access
Semantic Scholar
Imatinib mesylate in the treatment of hematologic malignancies
P. Piccaluga, M. Rondoni, S. Paolini, G. Rosti +2 more
2007Expert Opinion on Biological Therapy24 citations
Semantic Scholar
Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells
Andrea Ghelli Luserna di Rorá, M. Ghetti, Lorenzo Ledda, A. Ferrari +17 more
2021Cell Biology and Toxicology23 citations Open access
Semantic Scholar
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an italian multicentric phase II study.
P. Piccaluga, M. Malagola, M. Rondoni, M. Arpinati +14 more
2007Haematologica17 citations Open access
Semantic Scholar
Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid Leukemia
G. Simonetti, D. Angeli, E. Petracci, Eugenio Fonzi +15 more
2021Frontiers in Oncology14 citations Open access
Semantic Scholar
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a
M. Fontana, J. Nanni, Andrea Ghelli Luserna di Rorá, E. Petracci +15 more
2021Biomedicines12 citations Open access
Semantic Scholar
Advances and potential treatment for Philadelphia chromosome-positive adult acute lymphoid leukaemia
P. Piccaluga, G. Martinelli, M. Rondoni, G. Visani +1 more
2006Expert Opinion on Biological Therapy12 citations
Semantic Scholar
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in “Real-Life”: The SEIFEM Experience
L. Fianchi, F. Guolo, F. Marchesi, C. Cattaneo +32 more
2023Cancers11 citations Open access
Semantic Scholar
BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a Phase 2 Multicenter GIMEMA CML Working Party Trial.
M. Bocchia, M. Defina, M. Ippoliti, M. Amabile +20 more
200911 citations
Semantic Scholar
Familial occurrence of systemic and cutaneous mastocytosis in an adult multicentre series
Ilaria Tanasi, M. Bonifacio, M. Pizzolato, Federica Irene Grifoni +16 more
2021British Journal of Haematology10 citations Open access
Semantic Scholar
A rare case of Hemoglobin Leiden interfering with the DIFF channel of Sysmex XE-2100
M. Rosetti, G. Poletti, A. Sensi, A. Ravani +3 more
2015Scandinavian Journal of Clinical and Laboratory Investigation10 citations
Semantic Scholar
Philadelphia Chromosome-Positive Leukemia Patients Who Harbor Imatinib-Resistant Mutations Have a Higher Likelihood of Developing Additional Mutations Associated with Resistance to Novel Tyrosine Kinase Inhibitors.
S. Soverini, A. Gnani, Sabrina Colarossi, F. Castagnetti +11 more
200710 citations
Semantic Scholar
Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q‐ deletion
M. Defina, M. Rondoni, A. Gozzetti, L. Aprile +4 more
2010British Journal of Haematology9 citations
Semantic Scholar
Response to Dasatinib in Patients with Aggressive Systemic Mastocytosis with D816V Kit Mutation.
M. Rondoni, S. Paolini, Sabrina Colarossi, P. Piccaluga +15 more
20079 citations
Semantic Scholar
Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients.
M. Ghetti, I. Vannini, M. Bochicchio, I. Azzali +14 more
2023Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie8 citations Open access
Semantic Scholar
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry.
S. Merante, V. Ferretti, C. Elena, V. Brazzelli +26 more
2018Future Oncology8 citations
Semantic Scholar
Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant)
P. Savini, M. Rondoni, Giovanni Poletti, A. Lanzi +6 more
2015Case Reports in Hematology8 citations Open access
Semantic Scholar
Hypereosinophilic syndrome and molecularly targeted therapy
G. Martinelli, M. Rondoni, E. Ottaviani, S. Paolini +1 more
20077 citations
Semantic Scholar
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted
M. Mancini, C. Monaldi, S. De Santis, C. Papayannidis +12 more
2023Biomarker Research6 citations Open access
Semantic Scholar
Serendipitous detection of Hemoglobin G-Ferrara variant with Sysmex DIFF channel.
M. Rosetti, G. Poletti, G. Ivaldi, M. Rondoni +2 more
2016Clinical Biochemistry6 citations
Semantic Scholar
Rearrangements of ATP5L‐KMT2A in acute lymphoblastic leukaemia
A. Ferrari, Andrea Ghelli Luserna di Rorá, C. Domizio, C. Papayannidis +9 more
2020British Journal of Haematology5 citations
Semantic Scholar
PDGFRalpha/FIP1L1-positive chronic eosinophilic leukemia presenting with retro-orbital localization: efficacy of imatinib treatment
E. Vigna, E. Lucia, M. Gentile, C. Mazzone +7 more
2008Cancer Chemotherapy and Pharmacology5 citations
Semantic Scholar
Optimal Duration of CPX-351 Treatment and Best Timing for Consolidation with Allogeneic Stem Cell Transplantation: Evidence from a Large Real-World Italian Study
F. Guolo, L. Fianchi, M. P. Martelli, P. Chiusolo +40 more
2023Blood4 citations Open access
Semantic Scholar
New monoclonal antibodies and tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemia.
F. Lanza, E. Maffini, F. Saraceni, E. Massari +5 more
2020Minerva Medica4 citations
Semantic Scholar
Compound BCR-ABL1 Kinase Domain Mutants: Prevalence, Spectrum and Correlation with Tyrosine Kinase Inhibitor Resistance in a Prospective Series of Philadelphia Chromosome-Positive Leukemia Patients Analyzed By Next Generation Sequencing
S. Soverini, L. Bavaro, M. Martelli, C. De Benedittis +43 more
2018Blood4 citations
Semantic Scholar
CPX-351 Induction in Secondary Acute Myeloblastic Leukemia: Extended Follow up from the Italian Compassionate Use Program
P. Minetto, F. Guolo, L. Fianchi, M. Clavio +35 more
2021Blood3 citations Open access
Semantic Scholar
Genome-Wide Molecular Portrait of Aggressive Systemic Mastocytosis and Mast Cell Leukemia Depicted By Whole Exome Sequencing and Copy Number Variation Analysis
S. Soverini, C. De Benedittis, M. Mancini, M. Rondoni +18 more
20153 citations
Semantic Scholar
The New Italian Mastocytosis Registry.
S. Merante, D. Magliacane, I. Neri, C. Pascutto +14 more
20103 citations
Semantic Scholar
Genome-Wide Analysis by High-Resolution SNP Array Identifies Novel Genomic Alterations in Acute Promyelocytic Leukemia (APL).
I. Iacobucci, E. Ottaviani, Federica Salmi, V. Guadagnuolo +18 more
20093 citations
Semantic Scholar
Long-Term Mutation Follow-up of Philadelphia-Chromosome Positive Leukemia Patients Treated with Second-Generation Tyrosine Kinase Inhibitors after Imatinib Failure Shows That Newly Acquired Bcr-Abl Kinase Domain Mutations Leading to Relapse Are Mainly Detected during the First Year.
S. Soverini, A. Gnani, Sabrina Colarossi, F. Castagnetti +18 more
20083 citations
Semantic Scholar
New Horizons in Immunology and Immunotherapy of Acute Leukemias and Related Disorders
F. Lanza, M. Rondoni, B. Zannetti
2023Cancers2 citations Open access
Semantic Scholar
Long-Term Real-World Experience of CPX-351 in Combined French-Italian Cohorts Identified High Rate of Negative Measurable Residual Disease (MRD) and Prolonged Overall Survival
T. Cluzeau, F. Guolo, Edmond Chiche, P. Minetto +26 more
2023Blood2 citations Open access
Semantic Scholar
Final Analysis for the Primary End-Point of Gimema AML1718, a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia
G. Marconi, A. Piciocchi, E. Audisio, C. Papayannidis +34 more
2023Blood2 citations Open access
Semantic Scholar
Combined Inhibition of Polo-Like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells
M. Mancini, C. Monaldi, S. De Santis, M. Rondoni +6 more
2022Cancers2 citations Open access
Semantic Scholar
Preliminary Results from CPX-351 Italian Compassionate Use Program Show High Response Rate and Good Tolerability in Poor Prognosis AML Patients
F. Guolo, P. Minetto, L. Fianchi, M. Rondoni +11 more
2019Blood2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Martinelli×26
Invite
G. Martinelli — researcher profile on SciRah
S. Soverini×16
Invite
S. Soverini — researcher profile on SciRah
C. Papayannidis×16
Invite
C. Papayannidis — researcher profile on SciRah
M. Baccarani×13
Invite
M. Baccarani — researcher profile on SciRah

×13

Invite

L. Pagano — researcher profile on SciRah

Invite

S. Paolini — researcher profile on SciRah

Invite

G. Rosti — researcher profile on SciRah

Invite

S. Merante — researcher profile on SciRah

Invite

D. Cilloni — researcher profile on SciRah

E. Ottaviani×8

Invite

E. Ottaviani — researcher profile on SciRah

I. Iacobucci×8

Invite

I. Iacobucci — researcher profile on SciRah

Invite

A. Candoni — researcher profile on SciRah